They further suggest that targeting extracellular IGFBP-5 in diseases such as SSc or IPF where IGFBP-5 levels are elevated may be a more appropriate strategy for ameliorating fibrosis. The gene discussed is IGFBP5; the disease is idiopathic pulmonary fibrosis.